<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25970" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Noonan Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Allen</surname>
            <given-names>Mary J.</given-names>
          </name>
          <aff>Lincoln Memorial University-DeBusk College of Osteopathic</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Mery Fitzgerald Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mary Allen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>9</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25970.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Noonan syndrome is typically a genetically inherited disorder with heterogeneous phenotypic manifestations that can change with age. The most consistent features are wide-set eyes, low-set ears, short stature, and pulmonic stenosis. Noonan syndrome is typically inherited in an autosomal dominant manner. At least 8 gene mutations can cause this syndrome, and patient presentation can range from mild to severe. Diagnostic criteria have been developed to aid in the diagnosis of Noonan syndrome. This activity describes the evaluation, diagnosis, and management of Noonan syndrome and stresses the role of team-based interprofessional care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess&#x000a0;the pathophysiology of Noonan syndrome.</p></list-item><list-item><p>Evaluate&#x000a0;the symptoms associated with Noonan syndrome.</p></list-item><list-item><p>Determine&#x000a0;how to evaluate for Noonan syndrome.</p></list-item><list-item><p>Communicate&#x000a0;how interprofessional team coordination can lead to a more rapid diagnosis of Noonan syndrome and subsequently decrease associated morbidity in affected patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25970&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25970">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25970.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Noonan syndrome is a genetically inherited disease with heterogeneous, phenotypic manifestations. Gene mutations involve the RAAS/MAPK (mitogen-activated protein kinase) signaling pathway. The patient presentation can range from mild to severe. Thus, Noonan syndrome is typically a clinical diagnosis.</p>
      </sec>
      <sec id="article-25970.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Noonan syndrome is a pleomorphic autosomal dominant inherited disease. Thus, parents with Noonan syndrome have a 50% chance of passing the mutation on to their children.&#x000a0;Noonan syndrome&#x000a0;has been associated with advanced paternal age. Noonan Syndrome can also occur via de novo mutation or sporadic mutation. The mutated genes are involved in the RAS/MAPK cell signaling pathway. Please refer to the pathology section for more information on the RAS/MAPK pathway.<xref ref-type="bibr" rid="article-25970.r1">[1]</xref><xref ref-type="bibr" rid="article-25970.r2">[2]</xref></p>
      </sec>
      <sec id="article-25970.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Noonan syndrome occurs in approximately 1 in 1000 to 2500. Since the inheritance pattern is autosomal dominant, it affects both females and males equally. Males may display cryptorchidism, thus making the diagnosis at a younger age.&#x000a0;Noonan syndrome&#x000a0;occurs across all ethnic groups equally.<xref ref-type="bibr" rid="article-25970.r1">[1]</xref><xref ref-type="bibr" rid="article-25970.r2">[2]</xref></p>
      </sec>
      <sec id="article-25970.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The RAS/MAPK pathway mutation in Noonan syndrome classifies&#x000a0;Noonan syndrome as RASopathy. RASopathies are genetic syndromes that involve germline mutations in the Ras/mitogen-activated protein kinase (MAPK) pathway. These syndromes include cardiofaciocutaneous syndrome, Costello syndrome, Neurofibromatosis type 1 (NF1), and LEOPARD syndrome. The Ras/MAPK pathway is needed for cell division, proliferation, differentiation, and migration. It is vital for healthy development. The most common mutation in Noonan syndrome occurs in the <italic toggle="yes">PTPN11</italic> gene. A smaller portion of mutations occurs in <italic toggle="yes">SOS1</italic>, <italic toggle="yes">RAF1</italic>, and&#x000a0;<italic toggle="yes">RIT1</italic>. Mutations in&#x000a0;<italic toggle="yes">PTPN11</italic>&#x000a0;can be inherited, autosomal dominant, or occur de&#x000a0;novo through sporadic mutation. The mutations involved in Noonan syndrome are considered a gain of function mutation, causing inappropriate prolongation of the RAS/MAPK signaling. The prolongation of the RAS/MAPK pathway gives way to the pleomorphic characteristics found in Noonan syndrome.<xref ref-type="bibr" rid="article-25970.r1">[1]</xref><xref ref-type="bibr" rid="article-25970.r2">[2]</xref></p>
      </sec>
      <sec id="article-25970.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Noonan syndrome has phenotypical heterogeneous manifestations, which change with age. The most consistent features are widely set eyes, low-set ears, short stature, and pulmonic stenosis. Diagnostic criteria&#x000a0;have&#x000a0;been developed to aid in the diagnosis of Noonan syndrome. Please refer to the attached table for the criteria. One of the more common features prenatally is increased nuchal translucency in utero. However, increased nuchal translucency is associated with other conditions, such as Down syndrome. Other manifestations include polyhydramnios from renal anomalies, congenital heart diseases, mild limb shortening, and fetal macrosomia. As noted before, the vague symptoms present in the prenatal period can elude to various other conditions. Therefore, the index of suspicion for Noonan Syndrome must be relatively high. If karyotyping is done, it reveals a normal karyotype, ruling out trisomies. Noonan syndrome should be considered in all fetuses with increased nuchal translucency, polyhydramnios, and cardiac abnormalities with a normal karyotype.</p>
        <p>For many with Noonan syndrome, there are no clinical manifestations at birth. Macrosomia and macrocephaly may be present. Cryptorchidism may be present in males. Males have an increased risk of infertility, even if without a previous diagnosis of cryptorchidism. Most females are not at risk for infertility. The most common congenital heart defects are pulmonic stenosis and hypertrophic cardiomyopathy; depending on the severity, it may or may not be detected in a routine physical. The infant may experience feeding difficulties and failure to thrive, hearing loss, and strabismus.&#x000a0;Noonan syndrome&#x000a0;is associated with intellectual and developmental delays. Patients may display delayed speech or motor milestones, deafness, and short stature.</p>
        <p>Distinct facial characteristics are formed in early childhood and change as people age. Features include hypertelorism, low-set ears, blue irises, ptosis, mild neck webbing, high forehead, down-slanting palpebral fissures, and epicanthic folds. In adulthood, facial features show signs of premature aging, and lengthening the jaw gives the face a triangular shape. Lymphatic dysplasia is common and can lead to early generalized lymphoedema in the extremities and abdomen. A fetal examination may show a cystic hygroma, a fluid-filled sac caused by a blockage in the lymphatic system. Patients may experience easy bruising or bleeding due to coagulopathy. The most common etiology is due to factor XI deficiency. Skeletal abnormalities are also common, such as pectus carinatum or pectus excavatum.<xref ref-type="bibr" rid="article-25970.r3">[3]</xref><xref ref-type="bibr" rid="article-25970.r4">[4]</xref><xref ref-type="bibr" rid="article-25970.r5">[5]</xref></p>
      </sec>
      <sec id="article-25970.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Noonan syndrome remains a clinical diagnosis. Molecular genetic testing can be done to confirm the diagnosis. Upon diagnosis of&#x000a0;Noonan syndrome, various organ systems should be&#x000a0;evaluated (see <bold>Image.</bold> Diagnostic Criteria for Noonan Syndrome). Along with a complete physical and neurological exam, the following should be considered:<xref ref-type="bibr" rid="article-25970.r3">[3]</xref><xref ref-type="bibr" rid="article-25970.r4">[4]</xref><xref ref-type="bibr" rid="article-25970.r5">[5]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac evaluation, including echocardiography and electrocardiograph</p>
          </list-item>
          <list-item>
            <p>Ophthalmologic evaluation</p>
          </list-item>
          <list-item>
            <p>Audiologic evaluation</p>
          </list-item>
          <list-item>
            <p>Renal ultrasound</p>
          </list-item>
          <list-item>
            <p>Coagulation profile for coagulopathies</p>
          </list-item>
          <list-item>
            <p>Development assessment.</p>
          </list-item>
          <list-item>
            <p>Imaging of chest and back for skeletal abnormalities</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25970.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no cure for Noonan syndrome as it is a genetically inherited disease. Management of Noonan syndrome is targeted toward symptomatic improvement and supportive care. Interprofessional care is often needed; multiple organ systems are to be addressed. Hearing tests and ophthalmic exams are appropriate throughout childhood. In males with cryptorchidism, orchiopexy should be performed&#x000a0;when the child is around&#x000a0;1 year old if the testes have not descended to reduce the risk of development of testicular cancer in adulthood. For congenital heart defects, an echo and ECG should be obtained. Even in patients without a diagnosis of cardiac defects, a cardiac evaluation is needed every&#x000a0;5 years. Short stature can be evaluated for the treatment of growth hormone. Appropriate supportive measures can be used to target lymphedema.<xref ref-type="bibr" rid="article-25970.r5">[5]</xref><xref ref-type="bibr" rid="article-25970.r6">[6]</xref></p>
      </sec>
      <sec id="article-25970.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for Noonan syndrome is broad. Many other chromosomal abnormalities can cause a similar constellation of symptoms of congenital heart defect, short stature, and developmental delay.</p>
        <list list-type="bullet">
          <list-item>
            <p>Turner syndrome
<list list-type="bullet"><list-item><p>Noonan syndrome has been referred to as &#x0201c;pseudo-Turner syndrome&#x0201d; due to the similarities between Turner and Noonan syndromes. Both syndromes display a webbed neck and short stature. However, only females are affected by Turner syndrome (45, X0), as the X chromosome is affected. Both males and females are affected by Noonan syndrome, and the karyotype is normal.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Noonan syndrome is considered a RASopathy since the genetic mutations affect the RAS/MAPK pathway. Other RASopathies exhibit similar features to those in Noonan syndrome. These conditions include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiofasciocutaneous syndrome</p>
          </list-item>
          <list-item>
            <p>Costello syndrome</p>
          </list-item>
          <list-item>
            <p>Neurofibromatosis 1</p>
          </list-item>
          <list-item>
            <p>Noonan syndrome with multiple lentigines (formerly called LEOPARD syndrome)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25970.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis in those with Noonan Syndrome depends on their phenotype's severity. The severity of the heart defect is linked to the mortality and morbidity of patients. Many patients have an average lifespan and minimal morbidity.<xref ref-type="bibr" rid="article-25970.r5">[5]</xref></p>
      </sec>
      <sec id="article-25970.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of the disease include developmental delay with cognitive deficits that limit functionality and require aggressive support services for the affected patient. Physical complications may be due to severe cardiac abnormalities, such as valvular stenosis and hypertrophic cardiomyopathy, requiring ongoing medical care. Some patients have bleeding disorders with frequent medical care for the management of bleeding diatheses.<xref ref-type="bibr" rid="article-25970.r7">[7]</xref><xref ref-type="bibr" rid="article-25970.r8">[8]</xref></p>
      </sec>
      <sec id="article-25970.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Genetic counseling can be offered to patients and their families.</p>
      </sec>
      <sec id="article-25970.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Parents and, eventually, patients need supportive services to help optimize the development and surroundings of the affected patients. Early referral should be made to the specialized support group called the Noonan Syndrome Support Group (NSSG), which is available to all patients.</p>
      </sec>
      <sec id="article-25970.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of Noonan syndrome require an interprofessional team that includes a geneticist, pediatrician, primary care provider, ENT surgeon, audiologist, ophthalmologist, and cardiologist. There is no cure for Noonan syndrome as it is a genetically inherited disease. Management of Noonan syndrome is targeted toward symptomatic improvement and supportive care. Interprofessional care is often needed; multiple organ systems are to be addressed. Hearing tests and ophthalmic exams are appropriate throughout childhood. In males with cryptorchidism, orchiopexy should be performed&#x000a0;when the child is approximately&#x000a0;1 year old if the testes have not descended. This procedure is done to reduce the risk of developing testicular cancer in adulthood. For congenital heart defects, an echo and ECG should be obtained. Even in patients without a diagnosis of cardiac defects, a cardiac evaluation is needed every&#x000a0;5 years. Short stature can be evaluated for the treatment of growth hormone. Appropriate supportive measures can be used to target lymphedema.<xref ref-type="bibr" rid="article-25970.r9">[9]</xref><xref ref-type="bibr" rid="article-25970.r10">[10]</xref><xref ref-type="bibr" rid="article-25970.r11">[11]</xref><xref ref-type="bibr" rid="article-25970.r6">[6]</xref></p>
      </sec>
      <sec id="article-25970.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25970&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25970">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/noonan-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25970">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25970/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25970">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25970.s16">
        <fig id="article-25970.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Diagnostic Criteria for Noonan Syndrome Bhambhani V, Muenke M. Noonan syndrome. <italic toggle="yes">Am Fam Physician.</italic> 2014;89(1):37-43.&#x000a0;</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="sadgfas" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25970.s17">
        <title>References</title>
        <ref id="article-25970.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rauen</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>The RASopathies.</article-title>
            <source>Annu Rev Genomics Hum Genet</source>
            <year>2013</year>
            <volume>14</volume>
            <fpage>355</fpage>
            <page-range>355-69</page-range>
            <pub-id pub-id-type="pmid">23875798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brennan</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Curry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Esplin</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Homeyer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Niemi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Seaver</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Hintz</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Hudgins</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.</article-title>
            <source>Am J Med Genet A</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>164A</volume>
            <issue>11</issue>
            <fpage>2814</fpage>
            <page-range>2814-21</page-range>
            <pub-id pub-id-type="pmid">25250515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Burgt</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Noonan syndrome.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>Jan</month>
            <day>14</day>
            <volume>2</volume>
            <fpage>4</fpage>
            <pub-id pub-id-type="pmid">17222357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhambhani</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Muenke</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Noonan syndrome.</article-title>
            <source>Am Fam Physician</source>
            <year>2014</year>
            <month>Jan</month>
            <day>01</day>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-43</page-range>
            <pub-id pub-id-type="pmid">24444506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Allanson</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tartaglia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gelb</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Noonan syndrome.</article-title>
            <source>Lancet</source>
            <year>2013</year>
            <month>Jan</month>
            <day>26</day>
            <volume>381</volume>
            <issue>9863</issue>
            <fpage>333</fpage>
            <page-range>333-42</page-range>
            <pub-id pub-id-type="pmid">23312968</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moniez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pienkowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lepage</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hamdi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Daudin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jouret</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cartault</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diene</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Verloes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cav&#x000e9;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Salles</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Tauber</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Edouard</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Noonan syndrome males display Sertoli cell-specific primary testicular insufficiency.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>179</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-418</page-range>
            <pub-id pub-id-type="pmid">30325180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Briggs</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Savla</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ramchandar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dimmock</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Le</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thornburg</surname>
                <given-names>CD</given-names>
              </name>
            </person-group>
            <article-title>The Evaluation of Hematologic Screening and Perioperative Management in Patients with Noonan Syndrome: A Retrospective Chart Review.</article-title>
            <source>J Pediatr</source>
            <year>2020</year>
            <month>May</month>
            <volume>220</volume>
            <fpage>154</fpage>
            <page-range>154-158.e6</page-range>
            <pub-id pub-id-type="pmid">32111381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takashio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hanatani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arima</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kaikita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsujita</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Double-chambered right ventricle complicated by hypertrophic obstructive cardiomyopathy diagnosed as Noonan syndrome.</article-title>
            <source>ESC Heart Fail</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>721</fpage>
            <page-range>721-726</page-range>
            <pub-id pub-id-type="pmid">32078254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koh</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Brett</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>AHM</given-names>
              </name>
              <name>
                <surname>Jamuar</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>EC</given-names>
              </name>
            </person-group>
            <article-title>The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome.</article-title>
            <source>Mol Genet Genomic Med</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>e00581</fpage>
            <pub-id pub-id-type="pmid">30784236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gurovich</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hanani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Bar</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Nadav</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fleischer</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gelbman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Basel-Salmon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Krawitz</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Kamphausen</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Zenker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Gripp</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Identifying facial phenotypes of genetic disorders using deep learning.</article-title>
            <source>Nat Med</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-64</page-range>
            <pub-id pub-id-type="pmid">30617323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25970.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hemmati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dearani</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Ammash</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Cetta</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schaff</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>Early Outcomes of Cardiac Surgery in Patients with Noonan Syndrome.</article-title>
            <source>Semin Thorac Cardiovasc Surg</source>
            <year>2019</year>
            <season>Autumn</season>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>507</fpage>
            <page-range>507-513</page-range>
            <pub-id pub-id-type="pmid">30576779</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
